Results 81 to 90 of about 1,450,892 (352)

Intein‐based modular chimeric antigen receptor platform for specific CD19/CD20 co‐targeting

open access: yesMolecular Oncology, EarlyView.
CARtein is a modular CAR platform that uses split inteins to splice antigen‐recognition modules onto a universal signaling backbone, enabling precise, scarless assembly without re‐engineering signaling domains. Deployed here against CD19 and CD20 in B‐cell malignancies, the design supports flexible multi‐antigen targeting to boost T‐cell activation and
Pablo Gonzalez‐Garcia   +9 more
wiley   +1 more source

Types for BioAmbients [PDF]

open access: yes, 2010
The BioAmbients calculus is a process algebra suitable for representing compartmentalization, molecular localization and movements between compartments.
Capecchi, Sara, Troina, Angelo
core   +4 more sources

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Expert consensus on technical specifications for ABO blood group detection in clinical laboratories in Shenzhen

open access: yesZhongguo shuxue zazhi
To meet the time-sensitive requirements of transfusion therapy, clinical laboratory testing for ABO blood typing must be conducted swiftly and accurately.
Blood Transfusion Branch of Shenzhen Medical Association Expert Consensus Writing Group on Technical Specifications for ABO Blood Group Detection in Clinical Laboratories in Shenzhen
doaj   +1 more source

Norovirus and Histo-Blood Group Antigens

open access: yesJapanese Journal of Infectious Diseases, 2011
Norovirus (NoV), a member of the family Caliciviridae, is a major cause of acute water- and food-borne nonbacterial gastroenteritis and forms antigenically diverse groups of viruses. Human NoVs are divided into at least three genogroups, genogroups I (GI), GII, and GIV, which contain at least 15, 18, and 1 genotypes, respectively.
openaire   +2 more sources

Blood types [PDF]

open access: yes, 2011
Krv je specifična tjelesna tekućina koja se sastoji od krvnih stanica i krvne plazme. Krvna grupa je klasificirana na temelju prisutnosti ili odsutnosti naslijeđenih antigena koji se nalaze na površini crvenih krvnih stanica.
Brižić, Matea
core   +2 more sources

Analogue peptides for the immunotherapy of human acute myeloid leukemia [PDF]

open access: yes, 2015
Accepted manuscript. The final publication is available at: http://link.springer.com/article/10.1007%2Fs00262-015-1762-9The use of peptide vaccines, enhanced by adjuvants, has shown some efficacy in clinical trials.
A Driessche Van   +102 more
core   +2 more sources

ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies [PDF]

open access: gold, 2022
Ryan Philip Jajosky   +10 more
openalex   +1 more source

Detection of circulating tumor DNA in colorectal cancer patients using a methylation‐specific droplet digital PCR multiplex

open access: yesMolecular Oncology, EarlyView.
We developed a cost‐effective methylation‐specific droplet digital PCR multiplex assay containing tissue‐conserved and tumor‐specific methylation markers. The assay can detect circulating tumor DNA with high accuracy in patients with localized and metastatic colorectal cancer.
Luisa Matos do Canto   +8 more
wiley   +1 more source

Pediatric patient with Bombay blood group: A rare case report

open access: yesSaudi Journal of Anaesthesia, 2015
Bombay blood group is a rare blood group in which there is the absence of H antigen and presence of anti-H antibodies. At the time of blood grouping, this blood group mimics O blood group due to the absence of H antigen, but it shows incompatibility with
Sudeshna Bhar (Kundu)   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy